The package inserts for both semaglutide and tirzepatide list a series of warnings and precautions that include thyroid tumors, acute inflammation of the pancreas (pancreatitis), acute gallbladder disease, acute kidney injury (that may stem from dehydration due to excess vomiting or diarrhea), allergic reactions, a heightened risk of bottoming out blood sugars while on blood sugarlowering medications, worsening eye disease for those with type 2 diabetes, an increase in heart rate requiring monitoring, and suicidal thoughts and behaviors
This journal can be helpful when discussing your treatment plan with your doctor
Check directly with your provider
a double-blind and placebo-controlled study
This is a steady process, and its important to keep that in mind throughout your journey
Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers